Search Article 
Advanced search 
Official publication of the American Biodontics Society and the Center for Research and Education in Technology
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2013  |  Volume : 4  |  Issue : 2  |  Page : 39-43

Bisphosphonates: An update to the general dentist

1 Department of Periodontics and Implantology, D.J. College of Dental Sciences and Research, Modinagar, Uttar Pradesh, India
2 P.G. Student, D.J. College of Dental Sciences and Research, Modinagar, Uttar Pradesh, India

Correspondence Address:
Varun Dahiya
D.J. College of Dental sciences and Research, Modinagar, Uttar Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2155-8213.113001

Rights and Permissions

Bisphosphonates (BP), included under host modulation therapy are drugs that inhibit bone resorption and commonly prescribed to prevent skeletal related changes in malignant diseases of bone and bone diseases such as osteoporosis. The sudden rise of this group of drugs is unfortunately because of the serious complication of osteonecrosis of jaws called Bisphosphonate related osteonecrosis of jaws which leads to many dental related complications. This literature review is undertaken to review the general recommendations to the dentist and clinical implications of BP's. The implications of BP's use in dentistry are still being determined.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded596    
    Comments [Add]    
    Cited by others 1    

Recommend this journal